Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells.
about
Clinical impact of recurrently mutated genes on lymphoma diagnostics: state-of-the-art and beyondIDH2R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma.Epigenetic therapy overcomes treatment resistance in T cell prolymphocytic leukemiaEnteropathy-Associated T-Cell Lymphoma.Diagnosis and management of extranodal NK/T cell lymphoma nasal type.Activating somatic mutations outside the SH2-domain of STAT3 in LGL leukemia.Concurrent Mutations in ATM and Genes Associated with Common γ Chain Signaling in Peripheral T Cell Lymphoma.Primary CNS T-cell Lymphomas: A Clinical, Morphologic, Immunophenotypic, and Molecular Analysis.ChimeRScope: a novel alignment-free algorithm for fusion transcript prediction using paired-end RNA-Seq data.A mix of S and ΔS variants of STAT3 enable survival of activated B-cell-like diffuse large B-cell lymphoma cells in culture.The 2016 revision of the World Health Organization classification of lymphoid neoplasms.JAK-STAT and G-protein-coupled receptor signaling pathways are frequently altered in epitheliotropic intestinal T-cell lymphoma.Diagnostic and Biological Significance of KIR Expression Profile Determined by RNA-Seq in Natural Killer/T-Cell Lymphoma.Type II enteropathy-associated T-cell lymphoma features a unique genomic profile with highly recurrent SETD2 alterations.Mutational Analysis of Extranodal NK/T-Cell Lymphoma Using Targeted Sequencing with a Comprehensive Cancer PanelMutations in the JAK/STAT and RAS signaling pathways are common in intestinal T-cell lymphomasGenetic landscape of T- and NK-cell post-transplant lymphoproliferative disordersImplementation of next generation sequencing into pediatric hematology-oncology practice: moving beyond actionable alterations.A three-signal model of T-cell lymphoma pathogenesisMature T-cell leukemias: Molecular and Clinical Aspects.Panel sequencing for clinically oriented variant screening and copy number detection in 142 untreated multiple myeloma patients.Whole transcriptome analysis reveals dysregulated oncogenic lncRNAs in natural killer/T-cell lymphoma and establishes MIR155HG as a target of PRDM1.A neutralized human LMP1-IgG inhibits ENKTL growth by suppressing the JAK3/STAT3 signaling pathway.Mature T- and NK-cell non-Hodgkin lymphoma in children and young adolescents.Clinical manifestations and pathogenesis of cutaneous lymphomas: current status and future directions.Intramolecular hydrophobic interactions are critical mediators of STAT5 dimerization.Cytokine receptor signaling is required for the survival of ALK- anaplastic large cell lymphoma, even in the presence of JAK1/STAT3 mutations.Lymphoma classification update: T-cell lymphomas, Hodgkin lymphomas, and histiocytic/dendritic cell neoplasms.The ClusPro web server for protein-protein docking.O-GlcNAcylation of STAT5 controls tyrosine phosphorylation and oncogenic transcription in STAT5-dependent malignancies.T-Cell Lymphoma: Recent Advances in Characterization and New Opportunities for Treatment.JAK/STAT pathway directed therapy of T-cell leukemia/lymphoma: Inspired by functional and structural genomics.Genetic Landscape and Classification of Peripheral T Cell Lymphomas.The diagnosis and management of NK/T-cell lymphomas.Diagnosis and classification of hematologic malignancies on the basis of genetics.Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profiling.Frequent BCOR aberrations in extranodal NK/T-Cell lymphoma, nasal type.Challenging perspectives on the cellular origins of lymphoma.Exome sequencing identifies somatic mutations of DDX3X in natural killer/T-cell lymphoma.Assessment of T-cell receptor repertoire and clonal expansion in peripheral T-cell lymphoma using RNA-seq data.
P2860
Q17149636-C561B1DA-F2A3-440B-8019-33FAF718C08AQ54899458-32AD7B85-7131-4614-A25E-6B262889522BQ54899912-AE80984F-ACF6-459F-ABBC-3FCC1234CBF3Q54930662-3D276511-5E4C-4901-91AB-CBC6C98A6800Q54955067-F80F8BF7-0A05-4293-B85F-EA0EDCAC88A3Q54955073-58091229-C038-4209-8F4C-80546EF42A4AQ54955074-1543E866-505B-4E5B-A972-3A0074BFFC12Q54955077-6F486682-32F0-406B-9331-D683FB827C3FQ54995532-E6245899-7A23-4AAF-B1CA-FAABE6F79A25
P1343
Q27027493-38F8B095-A7E2-4942-A653-1B44068A19B5Q27853198-EED9356C-03E4-4ED2-8E7E-316EA53BDCE4Q28263993-9967DFBE-3306-4486-93BF-7D7DCA4A3ACCQ30239728-28F3C0C9-4BEF-4D73-9477-488F049AE3FDQ30249309-D19C4FAB-DE7F-4E13-A45B-94E98CAB291DQ30278603-DBC9AD61-0AE3-44C0-B1D8-D11B3206173FQ35832062-150E311A-85B3-4D07-9C66-70EE25E3B753Q36277681-705EF2A5-BED4-4285-AA2C-5B98C1EC0A22Q36363386-314E14D5-E66D-4B8D-8026-1366A4CF02D4Q36507578-C211A7DA-3A04-4BD5-B6D3-85841854F523Q36920426-FFB9342E-C93E-4D9D-B361-5B29DD8DF652Q36974344-4B446CE8-D787-4D09-82C4-FBD087083B98Q36990211-26E7D0F7-E4FB-47E3-BDB1-59C4BE43C22AQ37257158-68DF1BE8-B695-45C7-B201-749FBD0C2C6DQ37324841-9AF6CF1C-094C-4B73-ABDD-8E8CADB6CA7CQ37389358-9F337ECE-DA83-4F6D-946B-686F5C5360F1Q37437248-384E9CD8-0267-4A64-B6D3-5F6D0092B98EQ37529593-CF950CB9-2EFE-42B5-8E79-030FD3C4F39FQ38593164-D4DE1F0B-1135-42D5-93C9-D46CB9AA939AQ38598546-D71E010A-777B-4C3B-9468-A6DA01A7D23FQ38686915-2FAE8230-39EB-49B0-9728-0D20A596F9C3Q38705023-9252B817-14B3-41ED-9103-A52FB7B3B077Q38724665-4F81F520-FF7C-4BA6-AED4-6DF303B70A58Q38780407-8F413F3C-A70B-4B91-B2A7-511DC7E87E1AQ38805440-12EC7604-2307-491D-9822-37A2B92F2515Q38810236-29846B55-D73D-4E65-9770-C0151BEC7C23Q38868306-0009F038-B75C-4938-911E-29D2959C5FBFQ38992646-0437D697-6DFA-4712-97A9-81606548C609Q39024817-A5B98D30-284A-4295-8712-E5FCB2EB1450Q39028183-22A33776-771F-43F0-BCBE-73E6865678DAQ39063866-979A8362-B1A3-4278-84E5-3AD36A792C1DQ39142126-1D51A045-71B8-47E5-A4C8-E45C6BE719F0Q39183278-C1784F90-82F0-4E3C-B6D8-56FDB95A24C5Q39243241-3D1CA900-9CE1-4135-86E7-15D9BDD066D8Q39363409-B92C20AC-B293-4744-8E2B-493B2DD18080Q40095304-FB7D9269-A6B8-4496-A740-F6C2F66F8061Q40101543-204F6450-DC2C-4056-8FE4-93F67A344D80Q40523569-40C08CB5-EB74-489D-AC7B-F824F17E1893Q40717160-22485C79-9A6E-4C5D-A423-8E615D2280FDQ41198594-07066C3A-319F-45D8-8E3E-2DAC245F3662
P2860
Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells.
@en
Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells.
@nl
type
label
Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells.
@en
Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells.
@nl
prefLabel
Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells.
@en
Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells.
@nl
P2093
P2860
P4510
P50
P356
P1476
Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells.
@en
P2093
Adam Cornish
Anna Scuto
Francesco d'Amore
Javeed Iqbal
John C Williams
John K C Chan
P2860
P2888
P356
10.1038/NCOMMS7025
P407
P50
P577
2015-01-14T00:00:00Z